Bao-Lu Chen
18Patents
8h-index
36Co-inventors
68Inventor score
Filing activity: Oct 22, 1996 → Jun 17, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6525102B1 | Stabilized liquid polypeptide-containing pharmaceutical compositions | Human Necessities | 96 | Expired |
| US7371373B2 | HSA-free formulations of interferon-β | Human Necessities | 40 | Expired |
| US8277810B2 | Antagonist anti-CD40 antibodies | Chemistry; Metallurgy | 27 | Active |
| US7807142B2 | Stabilized liquid polypeptide-containing pharmaceutical compositions | Human Necessities | 21 | Expired |
| US6323326A | Method of solubilizing, purifying, and refolding protein | Chemistry; Metallurgy | 13 | Expired |
| US7399463B2 | HSA-free formulations of interferon-beta | Human Necessities | 10 | Expired |
| US5888968A | TFPI formulation | Chemistry; Metallurgy | 10 | Expired |
| US6887462B2 | HSA-free formulations of interferon-beta | Human Necessities | 9 | Expired |
| US7030086B2 | Stabilized liquid polypeptide-containing pharmaceutical compositions | Human Necessities | 8 | Expired |
| US8945564B2 | Antagonist anti-CD40 antibody pharmaceutical compositions | Chemistry; Metallurgy | 7 | Active |
| US7973136B2 | Optimized anti-CD30 antibodies | Chemistry; Metallurgy | 7 | Active |
| US6319896A | Method of solubilizing, purifying, and refolding protein | Chemistry; Metallurgy | 6 | Expired |
| US9574006B2 | Optimized anti-CD30 antibodies | Chemistry; Metallurgy | 4 | Active |
| US7892531B2 | HSA-free formulations of interferon-β | Human Necessities | 1 | Active |
| US7022672B2 | Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor | Chemistry; Metallurgy | 0 | Expired |
| US7659248B2 | Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins | Chemistry; Metallurgy | 0 | Active |
| US7226757B2 | Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor | Chemistry; Metallurgy | 0 | Expired |
| US8333958B2 | HSA-free formulations of interferon-Beta | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.